Title Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design. Journal, issue, pages Chemmedchem , Vol. 18, Page e202200615-e202200615, Year 2023Publish date Oct 19, 2022 (structure data deposition date) AuthorsKrieger, J. / Sorrell, F.J. / Wegener, A.A. / Leuthner, B. / Machrouhi-Porcher, F. / Hecht, M. / Leibrock, E.M. / Muller, J.E. / Eisert, J. / Hartung, I.V. / Schlesiger, S. External links Chemmedchem / PubMed:36749883Methods X-ray diffraction Resolution 1.72 - 3.18 Å Structure data PDB-8bdi : Structure viewer VCB in complex with compound 32 Method : X-RAY DIFFRACTION / Resolution : 2.108 Å
PDB-8bdj : Structure viewer VCB in complex with compound 30 Method : X-RAY DIFFRACTION / Resolution : 2.02 Å
PDB-8bdl : Structure viewer VCB in complex with compound 27 Method : X-RAY DIFFRACTION / Resolution : 2.295 Å
PDB-8bdm : Structure viewer VCB in complex with compound 26 Method : X-RAY DIFFRACTION / Resolution : 2.021 Å
PDB-8bdn : Structure viewer VCB in complex with compound 23 Method : X-RAY DIFFRACTION / Resolution : 2.76 Å
PDB-8bdo : Structure viewer VCB in complex with compound 21 Method : X-RAY DIFFRACTION / Resolution : 2.8 Å
PDB-8bds : Structure viewer Ternary complex between VCB, BRD4-BD1 and PROTAC 48 Method : X-RAY DIFFRACTION / Resolution : 1.72 Å
PDB-8bdt : Structure viewer Ternary complex between VCB, BRD4-BD2 and PROTAC 51 Method : X-RAY DIFFRACTION / Resolution : 2.7 Å
PDB-8bdx : Structure viewer Ternary complex between VCB, BRD4-BD2 and PROTAC 48 Method : X-RAY DIFFRACTION / Resolution : 2.93 Å
PDB-8beb : Structure viewer Ternary complex between VCB, BRD4-BD1 and PROTAC 49 Method : X-RAY DIFFRACTION / Resolution : 3.18 Å
Chemicals ChemComp-QF7 : Structure viewer (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-3-(methylamino)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-3-oxidanylidene-propyl]-4-oxidanyl-pyrrolidine-2-carboxamide
ChemComp-QE0 : Structure viewer (2~{S},4~{R})-~{N}-[(1~{S})-1-[4-chloranyl-2-(2-methoxyethoxy)phenyl]ethyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
ChemComp-QF3 : Structure viewer (2~{S},4~{R})-~{N}-[(1~{S})-1-[2-(2-methoxyethoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
ChemComp-QE9 : Structure viewer (2~{S},4~{R})-~{N}-[[2-(2-methoxyethoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
ChemComp-QFR : Structure viewer (2~{R})-3-methyl-1-[(2~{S},4~{R})-2-[(5~{R})-5-methyl-5-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-4~{H}-1,2,4-oxadiazol-3-yl]-4-oxidanyl-pyrrolidin-1-yl]-2-(3-methyl-1,2-oxazol-5-yl)butan-1-one
ChemComp-QFF : Structure viewer (2~{S},4~{R})-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-~{N}-[4-(4-methyl-1,3-thiazol-5-yl)phenoxy]-4-oxidanyl-pyrrolidine-2-carboxamide
ChemComp-QIY : Structure viewer (2S,4R)-N-[(1S)-1-(4-chlorophenyl)-3-[2-[2-[2-[2-[2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8$l^{5},11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethylamino]-3-oxidanylidene-propyl]-1-[(2R)-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
ChemComp-QLX : Structure viewer (2~{S},4~{R})-~{N}-[(1~{S})-3-[2-[2-[2-[2-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethylamino]-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-3-oxidanylidene-propyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
ChemComp-QIK : Structure viewer (2~{S},4~{R})-~{N}-[(1~{S})-3-[4-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoylamino]butylamino]-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-3-oxidanylidene-propyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
Source homo sapiens (human) Keywords LIGASE / PROTAC / degrader / complex / E3 ligase / VHL / VCB / VH032 / Ternary complex